HEALTH● LOWAug 6 · Aug 6, 2026, 2:32 AM
Zevra outlines CHMP reexamination timing with Q4 opinion expected, as MIPLYFFA Orange Book listing extends to 2041
Seeking Alpha Tech
Zevra has outlined the timing for its CHMP reexamination, with an opinion anticipated in the fourth quarter. The company's MIPLYFFA Orange Book listing has also been extended until 2041.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH53m agoNAFDAC destroys N1.5trn fake Products, secures 64 convictionsVanguard NigeriaHEALTH1h agoSHRC calls for enquiry into patient’s death following fall from hospital bedThe HinduHEALTH2h agoBLS projects nurse practitioners as the fastest - growing job by 41 % foxbusiness.com · United StatesHEALTH2h agoBhutan First in WHO South-East Asia to End Dog-Transmitted Human RabiesHuman Progress